Eisele, Yvonne S <br/><br/>
Gleevec increases levels of the amyloid precursor protein intracellular domain and of the amyloid-beta degrading enzyme neprilysin.  [electronic resource] 

 -  Molecular biology of the cell  Sep 2007 
 - 3591-600 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1059-1524 
<br/><br/><label>Standard No.: </label>10.1091/mbc.e07-01-0035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ammonium Chloride--pharmacology<br/>Amyloid Precursor Protein Secretases--antagonists & inhibitors<br/>Amyloid beta-Protein Precursor--chemistry<br/>Benzamides<br/>Cell Line, Tumor<br/>Dose-Response Relationship, Drug<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Imatinib Mesylate<br/>Models, Biological<br/>Neprilysin--genetics<br/>Nerve Tissue Proteins--metabolism<br/>Nuclear Proteins--metabolism<br/>Peptide Fragments--metabolism<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Structure, Tertiary<br/>Pyrimidines--pharmacology<br/>Up-Regulation--drug effects